Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · IEX Real-Time Price · USD
32.47
-1.20 (-3.56%)
May 17, 2024, 4:00 PM EDT - Market closed

Collegium Pharmaceutical Revenue

Collegium Pharmaceutical had revenue of $566.92M in the twelve months ending March 31, 2024, with 8.00% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $144.92M with 0.11% year-over-year growth. In the year 2023, Collegium Pharmaceutical had annual revenue of $566.77M with 22.17% growth.

Revenue (ttm)
$566.92M
Revenue Growth
+8.00%
P/S Ratio
1.87
Revenue / Employee
$2,877,782
Employees
197
Market Cap
1.06B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023566.77M102.83M22.17%
Dec 31, 2022463.93M187.07M67.56%
Dec 31, 2021276.87M-33.15M-10.69%
Dec 31, 2020310.02M13.32M4.49%
Dec 31, 2019296.70M16.29M5.81%
Dec 31, 2018280.41M251.94M884.73%
Dec 31, 201728.48M26.77M1,564.29%
Dec 31, 20161.71M--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition